190 related articles for article (PubMed ID: 22505018)
1. Multimodal interventional molecular imaging of tumor margins and distant metastases by targeting αvβ3 integrin.
Bunschoten A; Buckle T; Visser NL; Kuil J; Yuan H; Josephson L; Vahrmeijer AL; van Leeuwen FW
Chembiochem; 2012 May; 13(7):1039-45. PubMed ID: 22505018
[TBL] [Abstract][Full Text] [Related]
2. Imaging integrin αvβ3 on blood vessels with 111In-RGD2 in head and neck tumor xenografts.
Terry SY; Abiraj K; Frielink C; van Dijk LK; Bussink J; Oyen WJ; Boerman OC
J Nucl Med; 2014 Feb; 55(2):281-6. PubMed ID: 24408894
[TBL] [Abstract][Full Text] [Related]
3. Reduction of renal uptake of 111In-DOTA-labeled and A700-labeled RAFT-RGD during integrin αvβ3 targeting using single photon emission computed tomography and optical imaging.
Briat A; Wenk CH; Ahmadi M; Claron M; Boturyn D; Josserand V; Dumy P; Fagret D; Coll JL; Ghezzi C; Sancey L; Vuillez JP
Cancer Sci; 2012 Jun; 103(6):1105-10. PubMed ID: 22448775
[TBL] [Abstract][Full Text] [Related]
4. Molecular Imaging of Breast Cancer: Role of RGD Peptides.
Chakravarty R; Chakraborty S; Dash A
Mini Rev Med Chem; 2015; 15(13):1073-94. PubMed ID: 26349490
[TBL] [Abstract][Full Text] [Related]
5. Monitoring glioma growth and tumor necrosis with the U-SPECT-II/CT scanner by targeting integrin αvβ3.
Shao G; Zhou Y; Wang F; Liu S
Mol Imaging; 2013; 12(1):39-48. PubMed ID: 23348790
[TBL] [Abstract][Full Text] [Related]
6. Technetium-99m-labeled Arg-Gly-Asp-conjugated alpha-melanocyte stimulating hormone hybrid peptides for human melanoma imaging.
Yang J; Guo H; Miao Y
Nucl Med Biol; 2010 Nov; 37(8):873-83. PubMed ID: 21055617
[TBL] [Abstract][Full Text] [Related]
7. Ligands for mapping alphavbeta3-integrin expression in vivo.
Schottelius M; Laufer B; Kessler H; Wester HJ
Acc Chem Res; 2009 Jul; 42(7):969-80. PubMed ID: 19489579
[TBL] [Abstract][Full Text] [Related]
8. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
[TBL] [Abstract][Full Text] [Related]
9. Multimodal imaging of integrin receptor-positive tumors by bioluminescence, fluorescence, gamma scintigraphy, and single-photon emission computed tomography using a cyclic RGD peptide labeled with a near-infrared fluorescent dye and a radionuclide.
Edwards WB; Akers WJ; Ye Y; Cheney PP; Bloch S; Xu B; Laforest R; Achilefu S
Mol Imaging; 2009; 8(2):101-10. PubMed ID: 19397855
[TBL] [Abstract][Full Text] [Related]
10. Noninvasive imaging of tumor integrin expression using (18)F-labeled RGD dimer peptide with PEG (4) linkers.
Liu Z; Liu S; Wang F; Liu S; Chen X
Eur J Nucl Med Mol Imaging; 2009 Aug; 36(8):1296-307. PubMed ID: 19296102
[TBL] [Abstract][Full Text] [Related]
11. Tumor targeting and imaging with dual-peptide conjugated multifunctional liposomal nanoparticles.
Rangger C; Helbok A; Sosabowski J; Kremser C; Koehler G; Prassl R; Andreae F; Virgolini IJ; von Guggenberg E; Decristoforo C
Int J Nanomedicine; 2013; 8():4659-71. PubMed ID: 24353415
[TBL] [Abstract][Full Text] [Related]
12. Impact of bifunctional chelators on biological properties of 111In-labeled cyclic peptide RGD dimers.
Shi J; Kim YS; Chakraborty S; Zhou Y; Wang F; Liu S
Amino Acids; 2011 Nov; 41(5):1059-70. PubMed ID: 20052508
[TBL] [Abstract][Full Text] [Related]
13. In Vivo Characterization of 4
Lobeek D; Franssen GM; Ma MT; Wester HJ; Decristoforo C; Oyen WJG; Boerman OC; Terry SYA; Rijpkema M
J Nucl Med; 2018 Aug; 59(8):1296-1301. PubMed ID: 29626124
[TBL] [Abstract][Full Text] [Related]
14. Pre-clinical Evaluation of a Cyanine-Based SPECT Probe for Multimodal Tumor Necrosis Imaging.
Stammes MA; Knol-Blankevoort VT; Cruz LJ; Feitsma HR; Mezzanotte L; Cordfunke RA; Sinisi R; Dubikovskaya EA; Maeda A; DaCosta RS; Bierau K; Chan A; Kaijzel EL; Snoeks TJ; van Beek ER; Löwik CW
Mol Imaging Biol; 2016 Dec; 18(6):905-915. PubMed ID: 27277828
[TBL] [Abstract][Full Text] [Related]
15. alpha(v)beta(3) Integrin-targeting radionuclide therapy and imaging with monomeric RGD peptide.
Yoshimoto M; Ogawa K; Washiyama K; Shikano N; Mori H; Amano R; Kawai K
Int J Cancer; 2008 Aug; 123(3):709-15. PubMed ID: 18498129
[TBL] [Abstract][Full Text] [Related]
16. Chemical and biological evaluations of an (111)in-labeled RGD-peptide targeting integrin alpha(V) beta(3) in a preclinical tumor model.
Ahmadi M; Sancey L; Briat A; Riou L; Boturyn D; Dumy P; Fagret D; Ghezzi C; Vuillez JP
Cancer Biother Radiopharm; 2008 Dec; 23(6):691-700. PubMed ID: 19111043
[TBL] [Abstract][Full Text] [Related]
17. [99mTc]HYNIC-RGD for imaging integrin alphavbeta3 expression.
Decristoforo C; Faintuch-Linkowski B; Rey A; von Guggenberg E; Rupprich M; Hernandez-Gonzales I; Rodrigo T; Haubner R
Nucl Med Biol; 2006 Nov; 33(8):945-52. PubMed ID: 17127166
[TBL] [Abstract][Full Text] [Related]
18. (64)Cu-labeled tetrameric and octameric RGD peptides for small-animal PET of tumor alpha(v)beta(3) integrin expression.
Li ZB; Cai W; Cao Q; Chen K; Wu Z; He L; Chen X
J Nucl Med; 2007 Jul; 48(7):1162-71. PubMed ID: 17574975
[TBL] [Abstract][Full Text] [Related]
19. Tumor targeting with radiolabeled alpha(v)beta(3) integrin binding peptides in a nude mouse model.
Janssen ML; Oyen WJ; Dijkgraaf I; Massuger LF; Frielink C; Edwards DS; Rajopadhye M; Boonstra H; Corstens FH; Boerman OC
Cancer Res; 2002 Nov; 62(21):6146-51. PubMed ID: 12414640
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]